Agenda

Date and TimeTitle
Aug 21, 2020 (Eastern)
9:54am - 10:00am
WELCOME AND INTRODUCTION

Session Chair: Dr. Yehuda Yandeslman, MD and Mikhail N. Kosiborod, MD

 

 

Aug 21, 2020 (Eastern)
10:00am - 11:49am
Session 1: COVID-19 in DM & CVD

Session Chair: Derek LeRoith, MD, PhD

Obesity, a Major Predictor of Mortality by COVID-19: Associations with DM & CVD and Implications for Therapy

Christos S. Mantzoros, MD, PhD

 

CVD Incidence & MOA in COVID-19: Vascular, Inflammatory & Thrombosis Implications

Mansoor Husain, MD

 

Ongoing Research of COVID-19 Complications & Management - Focus on DARE-19

Mikhail N. Kosiborod, MD

 

Diabetes and the COVID-19 Pandemic

Zachary Bloomgarden, MD

 

The Impact of COVID-19 on Cardiovascular Care & the Post-Pandemic Future of Cardiovascular Prevention

Laurence Sperling, MD

 

Panel Discussion & Live Q&A

Aug 21, 2020 (Eastern)
11:49am - 12:00pm
LIVE Q&A —Session 1: COVID-19 in DM & CVD

Session Chair: Derek LeRoith, MD, PhD

Obesity, a Major Predictor of Mortality by COVID-19: Associations with DM & CVD and Implications for Therapy

Christos S. Mantzoros, MD, PhD

 

CVD Incidence & MOA in COVID-19: Vascular, Inflammatory & Thrombosis Implications

Mansoor Husain, MD

 

Ongoing Research of COVID-19 Complications & Management - Focus on DARE-19

Mikhail N. Kosiborod, MD

 

Diabetes and the COVID-19 Pandemic

Zachary Bloomgarden, MD

 

The Impact of COVID-19 on Cardiovascular Care & the Post-Pandemic Future of Cardiovascular Prevention

Laurence Sperling, MD

 

Panel Discussion & Live Q&A

Aug 21, 2020 (Eastern)
12:00pm - 12:59pm
Session 2: CONTEMPORARY CONCEPTS & MANAGEMENT OF DM & ASCVD

Session Chair: Laurence Sperling, MD

Epigenetic Modification to Reduce CVD in People with DM

Kausik Ray, MD

 

The Surgical Management of CAD in DM

Michael E. Farkouh, MD

 

Update on CVOT's

Michael H. Davidson, MD

 

Panel Discussion & Live Q&A

Aug 21, 2020 (Eastern)
12:59pm - 1:20pm
LIVE Q&A —Session 2: CONTEMPORARY CONCEPTS & MANAGEMENT OF DM & ASCVD

Session Chair: Laurence Sperling, MD

Epigenetic Modification to Reduce CVD in People with DM

Kausik Ray, MD

 

The Surgical Management of CAD in DM

Michael E. Farkouh, MD

 

Update on CVOT's

Michael H. Davidson, MD

 

Panel Discussion & Live Q&A

Aug 21, 2020 (Eastern)
1:20pm - 2:05pm
Industry Session (Non-CME): VASCEPA® (icosapent ethyl): Elevating the Standard of Care – Sponsored by: AMARIN
Aug 21, 2020 (Eastern)
2:05pm - 3:24pm
Session 3: CONTROVERSIES IN LIPID MANAGEMENT

Session Chairs: Paul S. Jellinger, MD, Kausik Ray, MD

 

"Back to the Future" with Lipid Therapy

Norman E. Lepor, MD

 

Should High Triglycerides Be Managed in Addition to a Statin & EPA?

Sergio Fazio, MD, PhD

 

DEBATE: SHOULD TREATMENT WITH PCSK9I BE RESERVED FOR LDL >100

Yes

Jennifer G. Robinson, MD

No

Steven E. Nissen, MD

Rebuttal

Rebuttal

Panel, Q&A, Audience Voting

 

 

Aug 21, 2020 (Eastern)
3:24pm - 3:45pm
LIVE Q&A — Session 3: CONTROVERSIES IN LIPID MANAGEMENT

Session Chairs: Paul S. Jellinger, MD, Kausik Ray, MD

 

"Back to the Future" with Lipid Therapy

Norman E. Lepor, MD

 

Should High Triglycerides Be Managed in Addition to a Statin & EPA?

Sergio Fazio, MD, PhD

 

DEBATE: SHOULD TREATMENT WITH PCSK9I BE RESERVED FOR LDL >100

Yes

Jennifer G. Robinson, MD

No

Steven E. Nissen, MD

Rebuttal

Rebuttal

Panel, Q&A, Audience Voting

 

 

Aug 21, 2020 (Eastern)
3:45pm - 5:03pm
Session 4: HEART IN DIABETES WITH CIRCULATION

Session Chair: Biykem Bozkurt, MD, PhD

 

Introduction

Biykem Bozkurt, MD, PhD

 

GLP1ra Exenatide and Heart Failure Outcomes

Robert J. Mentz, MD

 

The Diabetes Paradox in Aortic Aneurysm

Joshua Beckman, MD

 

Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of CVD in T1DM

Mrya A. Lipes, MD

 

Heart Failure Risk Stratification and Efficacy of SGLT2i in Patients with T2DM

Benjamin M. Scirica, MD

 

Sugar and Artifically-Sweetened Beverages and CVD Risk- Reason for Concern?

Alice H. Lichenstein, D. Sc

 

Panel, Live Q&A

 

Aug 21, 2020 (Eastern)
5:02pm - 5:25pm
LIVE Q&A — Session 4: HEART IN DIABETES WITH CIRCULATION

Session Chair: Biykem Bozkurt, MD, PhD

 

Introduction

Biykem Bozkurt, MD, PhD

 

GLP1ra Exenatide and Heart Failure Outcomes

Robert J. Mentz, MD

 

The Diabetes Paradox in Aortic Aneurysm

Joshua Beckman, MD

 

Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of CVD in T1DM

Mrya A. Lipes, MD

 

Heart Failure Risk Stratification and Efficacy of SGLT2i in Patients with T2DM

Benjamin M. Scirica, MD

 

Sugar and Artifically-Sweetened Beverages and CVD Risk- Reason for Concern?

Alice H. Lichenstein, D. Sc

 

Panel, Live Q&A

 

Aug 21, 2020 (Eastern)
5:25pm - 6:29pm
Day 1 Summary, Live Q&A

5:25pm - 6:15pm

Aug 22, 2020 (Eastern)
10:00am - 10:55am
Session 5: WOMEN & CVD

Session Chair: Norman E. Lepor, MD

 

Cardiovascular Disease Risk Reduction in Menopausal Women

Gina P. Lundberg, MD

 

Gender Differences in Cardiovascular Imaging

Matthew J. Budoff, MD

 

Sex Differences in DM & CVD Across Outcome Studies

Neha J. Pagidipati, MD

 

Panel Discussion & Live Q&A

Aug 22, 2020 (Eastern)
10:55am - 11:20am
LIVE Q&A — Session 5: WOMEN & CVD

Session Chair: Norman E. Lepor, MD

 

Cardiovascular Disease Risk Reduction in Menopausal Women

Gina P. Lundberg, MD

 

Gender Differences in Cardiovascular Imaging

Matthew J. Budoff, MD

 

Sex Differences in DM & CVD Across Outcome Studies

Neha J. Pagidipati, MD

 

Panel Discussion & Live Q&A

Aug 22, 2020 (Eastern)
11:20am - 12:36pm
Session 6: ADVANCES IN ANTI-THROMBOTICS IN DIABETES

Session Chair: Deepak L. Bhatt, MD

 

Insights on Anti-Thrombotics Strategies in Diabetes from THEMIS PCI

Philippe Gabriel Steg, MD

 

Anti-Thrombotics Therapy in Diabetes

Richard C. Becker, MD

 

COMPASS

Deepak L. Bhatt, MD

 

Panel Discussion & Live Q&A

Aug 22, 2020 (Eastern)
12:37pm - 12:40pm
QUICK BREAK BEFORE "LUMINARY IN CARDIOMETABOLIC MEDICINE" AWARD PRESENTATION

QUICK BREAK BEFORE "LUMINARY IN CARDIOMETABOLIC MEDICINE" AWARD PRESENTATION

Grab your lunch and your favorite beverage for the upcoming award presentation and keynote.

Aug 22, 2020 (Eastern)
12:40pm - 1:18pm
AWARD PRESENTATION "Luminary in Cardiometabolic Medicine"

Presented by: Deepak L. Bhatt, MD, Mikhail N. Kosiborod, MD, Yehuda Handelsman, MD

 

Awards Presentation

 

KEYNOTE: SGLT2i and the Birth of 2 PARADIGM SHIFTS in Clinical Care

Eugene Braunwald, MD

 

Live Q&A

Aug 22, 2020 (Eastern)
1:18pm - 1:45pm
LIVE Q&A – AWARD PRESENTATION "Luminary in Cardiometabolic Medicine"

Presented by: Deepak L. Bhatt, MD, Mikhail N. Kosiborod, MD, Yehuda Handelsman, MD

 

Awards Presentation

 

KEYNOTE: SGLT2i and the Birth of 2 PARADIGM SHIFTS in Clinical Care

Eugene Braunwald, MD

 

Live Q&A

Aug 22, 2020 (Eastern)
1:45pm - 2:15pm
The Continuum of Heart Failure – Sponsored by: Boehringer Ingelheim & Lilly – Industry Session (Non-CME)
Aug 22, 2020 (Eastern)
2:15pm - 3:18pm
Session 7: PRACTICE RECOMMENDATIONS IN DIABETES & ASCVD - AN UPDATE

Session Chairs: Lawrence A. Leiter, MD, Sergio Fazio, MD, PhD

 

Contemporary Lipid Management Recommendations in the Prevention of CVD

Christie M. Ballantyne, MD

 

ESC/EASD 2019 CVD in DM Guidelines

Peter J. Grant, MD

 

ADA-EASD Practice Recommendations' 2019 Update

David A. D'Alessio, MD

 

AACE DM & Lipids Practice Recommendations

Yehuda Handelsman, MD

 

Panel Discussion & Live Q&A

Aug 22, 2020 (Eastern)
3:18pm - 3:35pm
LIVE Q&A — Session 7: PRACTICE RECOMMENDATIONS IN DIABETES & ASCVD - AN UPDATE

Session Chairs: Lawrence A. Leiter, MD, Sergio Fazio, MD, PhD

 

Contemporary Lipid Management Recommendations in the Prevention of CVD

Christie M. Ballantyne, MD

 

ESC/EASD 2019 CVD in DM Guidelines

Peter J. Grant, MD

 

ADA-EASD Practice Recommendations' 2019 Update

David A. D'Alessio, MD

 

AACE DM & Lipids Practice Recommendations

Yehuda Handelsman, MD

 

Panel Discussion & Live Q&A

Aug 22, 2020 (Eastern)
3:35pm - 4:56pm
CME Supported Symposium: The Prevention and Management of the Heart Failure

This CME Symposium is supported by an educational grant from AstraZeneca.

Symposium Chairs: Javed Butler, MD, Yehuda Handelsman, MD

Agenda:

Introduction

Epidemiology and Pathophysiology of HF
Mikhail N. Kosiborod, MD

 

Preventing HF & HF Adverse Outcomes: A Look at the Evidence
Javed Butler, MD

 

The Present and Future Management of HFrEF and HFpEF
Biykem Bozkurt, MD, PhD

Panel Discussion:
Practical Management of HF - Case Based\
Biykem Bozkurt, MD, PhD
Yehuda Handelsman, MD
Mikhail N. Kosiborod, MD
Christian W. Mende, MD
Muthiah Vaduganathan, MD

Moderator
Javed Butler, MD

Live Q&A

 

 

 

Aug 22, 2020 (Eastern)
4:56pm - 5:15pm
LIVE Q&A — CME Supported Symposium: The Prevention and Management of the Heart Failure

Symposium Chairs: Javed Butler, MD, Yehuda Handelsman, MD

 

Introduction

 

Epidemiology and Pathophysiology of HF

Mikhail N. Kosiborod, MD

 

Preventing HF & HF Adverse Outcomes: A Look at the Evidence

Javed Butler, MD

 

The Present and Future Management of HFrEF and HFpEF

Biykem Bozkurt, MD, PhD

 

Panel Discussion: Practical Management of HF - Case Based

Biykem Bozkurt, MD, PhD, Yehuda Handelsman, MD

Mikhail N. Kosiborod, MD, Christian W. Mende, MD, Muthiah Vaduganathan, MD

Moderator

Javed Butler, MD

Live Q&A

 

 

 

Aug 22, 2020 (Eastern)
5:15pm - 6:17pm
Day 2 Summary, Live Q&A

5:15pm - 6:15pm

Aug 23, 2020 (Eastern)
10:00am - 11:27am
Session 8: MANAGEMENT OF HYPERGLYCEMIA TO IMPROVE OUTCOMES

Session Chairs: George Grunberger, MD, Daniel Einhorn,MD

 

Preventing Diabetes to Prevent CVD: Is it Chicken or Egg? (or Turkey?!)

Silvio E. Inzucchi, MD

 

Management Hyperglycemia in T2DM with Class 4-5 CKD

Vivian A. Fonseca, MD

 

The Combination of SGLT2i and GLP1-ra's Impact on CVD

Ralph A. DeFronzo, MD

 

Adjunctive Therapies for Type 1 Diabetes: Thinking Beyond Glucose Control

Richard E. Pratley, MD

 

Panel Discussion & Live Q&A

Aug 23, 2020 (Eastern)
11:27am - 11:40am
LIVE Q&A – Session 8: MANAGEMENT OF HYPERGLYCEMIA TO IMPROVE OUTCOMES

Session Chairs: George Grunberger, MD, Daniel Einhorn,MD

 

Preventing Diabetes to Prevent CVD: Is it Chicken or Egg? (or Turkey?!)

Silvio E. Inzucchi, MD

 

Management Hyperglycemia in T2DM with Class 4-5 CKD

Vivian A. Fonseca, MD

 

The Combination of SGLT2i and GLP1-ra's Impact on CVD

Ralph A. DeFronzo, MD

 

Adjunctive Therapies for Type 1 Diabetes: Thinking Beyond Glucose Control

Richard E. Pratley, MD

 

Panel Discussion & Live Q&A

Aug 23, 2020 (Eastern)
11:40am - 12:32pm
Session 9:THE TREATMENT OF DIABETES

Session Chairs: Ralph A. DeFronzo,MD, Vivian A. Fonseca,MD

DEBATE: EARLY COMBINATION VS SEQUENTIAL THERAPY- IMPACT ON DM & CVD

 

Sequential Therapy

David M. Nathan,MD

 

Early Combination Therapy

Stefano Del Prato, MD

 

Panel, Q&A, Audience Voting

 

Aug 23, 2020 (Eastern)
12:33pm - 12:45pm
LIVE VOTING + Q&A — Session 9: THE TREATMENT OF DIABETES

Session Chairs: Ralph A. DeFronzo,MD, Vivian A. Fonseca,MD

DEBATE: EARLY COMBINATION VS SEQUENTIAL THERAPY- IMPACT ON DM & CVD

 

Sequential Therapy

David M. Nathan,MD

 

Early Combination Therapy

Stefano Del Prato, MD

 

Panel, Q&A, Audience Voting

 

Aug 23, 2020 (Eastern)
12:45pm - 1:16pm
Industry Session (Non-CME): The Next Horizon in the Heart Failure Treatment Paradigm for Patients with HFrEF – Sponsored by: AstraZeneca
Aug 23, 2020 (Eastern)
1:16pm - 1:30pm
LIVE Q&A – Industry Session (Non-CME): The Next Horizon in the Heart Failure Treatment Paradigm for Patients with HFrEF – Sponsored by: AstraZeneca
Aug 23, 2020 (Eastern)
1:30pm - 2:45pm
Session 10: HEART IN DIABETES WITH JACC

Session Chair: Michael E. Farkouh, MD

 

Introduction

Michael E. Farkouh, MD

 

Atrial Fibrillation and Diabetes Mellitus

Allen Wang, MD

 

Therapeutic Care, Health-Related Quality of Life, Clincial Outcomes in Comorbid HFrEF and DM: The CHAMP-HF Registry

Muthiah Vaduganathan, MD

 

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes

Daniel Gudbjartsson, PhD

 

SGLT2 Inhibition and Cardiorenal Protection

Julie A. Lovshin, MD, PhD

 

Individualizing Revascularization Strategy for Diabetic Patients with Multivessel CAD

David J. Cohen, MD

 

Panel, Live Q&A

 

 

Aug 23, 2020 (Eastern)
2:45pm - 3:10pm
LIVE Q&A Session 10: HEART IN DIABETES WITH JACC

Session Chair: Michael E. Farkouh, MD

 

Introduction

Michael E. Farkouh, MD

 

Atrial Fibrillation and Diabetes Mellitus

Allen Wang, MD

 

Therapeutic Care, Health-Related Quality of Life, Clincial Outcomes in Comorbid HFrEF and DM: The CHAMP-HF Registry

Muthiah Vaduganathan, MD

 

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes

Daniel Gudbjartsson, PhD

 

SGLT2 Inhibition and Cardiorenal Protection

Julie A. Lovshin, MD, PhD

 

Individualizing Revascularization Strategy for Diabetic Patients with Multivessel CAD

David J. Cohen, MD

 

Panel, Live Q&A

 

 

Aug 23, 2020 (Eastern)
3:10pm - 4:37pm
Session 11: HEART FAILURE: STATE-OF-THE-ART

Session Chairs: Mansoor Husain, MD

 

Impact of Blood Pressure:Variability on CHF

Peter Reaven, MD

 

HF in DM - Is it Morbidity Not Morbidity We Need to Focus on?

Mark Kearney, MD

 

Physiologic Monitoring of Heart Failure

Robert J. Chilton, DO

 

DAPA-HF and Next Steps with SGLT2 Inhibitors in Heart Failure

John McMurray, MD

 

Panel Discussion & Live Q&A

 

Aug 23, 2020 (Eastern)
4:37pm - 5:00pm
LIVE Q&A — Session 11: HEART FAILURE: STATE-OF-THE-ART

Session Chairs: Mansoor Husain, MD

 

Impact of Blood Pressure:Variability on CHF

Peter Reaven, MD

 

HF in DM - Is it Morbidity Not Morbidity We Need to Focus on?

Mark Kearney, MD

 

Physiologic Monitoring of Heart Failure

Robert J. Chilton, DO

 

DAPA-HF and Next Steps with SGLT2 Inhibitors in Heart Failure

John McMurray, MD

 

Panel Discussion & Live Q&A

 

Aug 23, 2020 (Eastern)
5:00pm - 6:30pm
Day 3 Summary, Live Q&A

5:00pm - 6:00pm

Aug 24, 2020 (Eastern)
10:00am - 11:02am
Session 12: GLP1-RA IN ASCVD & THE KIDNEY

Session Chairs: Richard E. Pratley, MD, Matthew R. Weir, MD

 

Mechanistic Insights into Cardiovascular Effects of GLP-1ra

Nikolaus Marx, MD

 

GLP1-ra Impact on the Kidney

Mark E. Cooper, AO, PhD

 

Role of GLP1-ra in Trials in HF Patients

Javed Butler, MD

 

Panel Discussion & Live Q&A

Aug 24, 2020 (Eastern)
11:02am - 11:15am
LIVE Q&A — GLP1-RA IN ASCVD & THE KIDNEY

Session Chairs: Richard E. Pratley, MD, Matthew R. Weir, MD

 

Mechanistic Insights into Cardiovascular Effects of GLP-1ra

Nikolaus Marx, MD

 

GLP1-ra Impact on the Kidney

Mark E. Cooper, AO, PhD

 

Role of GLP1-ra in Trials in HF Patients

Javed Butler, MD

 

Panel Discussion & Live Q&A

Aug 24, 2020 (Eastern)
11:15am - 12:49pm
Session 13: The Kidney & The Heart

Session Chairs: Christian W. Mende,MD, Robert J. Chilton, DO

11:15am - 11:35am

The Role of Sodium Restrictions in HF in Type 2 Diabetes

Jeffrey Testanti, MD

11:35am - 11:55am

Effects of SGLT2i on BP and CKD Progression: Is it Dependent or Independent of BP?

Matthew R. Weir, MD

11:55am - 12:15pm

How Do SGLT2i Reduce Cardiorenal Outcomes and Atrial Fibrillations

Subodh Verman, MD

12:15pm - 12:35pm

Impact of Kidney Function on Mortality in the CVOT's

George L. Bakris, MD

12:35pm - 1:00pm

Panel Discussion & Live Q&A

Aug 24, 2020 (Eastern)
12:49pm - 1:00pm
LIVE Q&A — Session 12: The Kidney & The Heart

Session Chairs: Christian W. Mende,MD, Robert J. Chilton, DO

11:15am - 11:35am

The Role of Sodium Restrictions in HF in Type 2 Diabetes

Jeffrey Testanti, MD

11:35am - 11:55am

Effects of SGLT2i on BP and CKD Progression: Is it Dependent or Independent of BP?

Matthew R. Weir, MD

11:55am - 12:15pm

How Do SGLT2i Reduce Cardiorenal Outcomes and Atrial Fibrillations

Subodh Verma, MD

12:15pm - 12:35pm

Impact of Kidney Function on Mortality in the CVOT's

George L. Bakris, MD

12:35pm - 1:00pm

Panel Discussion & Live Q&A

Aug 24, 2020 (Eastern)
1:00pm - 1:45pm
Industry Session (Non-CME): Atherosclerotic Cardiovascular Disease (ASCVD) in Diabetes: Identifying High Risk and Reducing the Burden of Elevated LDL-C – Sponsored by: Novartis
Aug 24, 2020 (Eastern)
1:45pm - 2:49pm
Session 14: Technology & Digital Health

Session Chair: Christos S. Mantzoros, MD, PhD

1:45pm - 2:05pm

Artificial Intelligence in the Future Management of Cardiovascular Disease and Diabetes

Irving K, Loh, MD

2:05pm - 2:25pm

The Implications of Digital Health for Cardiometabolic Conditions

Michael P. Snyder, PhD

2:25pm - 2:45pm

Is There an App for That? Role of Devices on Diabetes and CVD Management

George Grunberger, MD

2:45pm - 3:00pm

Panel Discussion & Live Q&A

Aug 24, 2020 (Eastern)
2:49pm - 3:00pm
LIVE Q&A —Session 14: Technology & Digital Health

Session Chair: Christos S. Mantzoros, MD, PhD

1:45pm - 2:05pm

Artificial Intelligence in the Future Management of Cardiovascular Disease and Diabetes

Irving K, Loh, MD

2:05pm - 2:25pm

The Implications of Digital Health for Cardiometabolic Conditions

Michael P. Snyder, PhD

2:25pm - 2:45pm

Is There an App for That? Role of Devices on Diabetes and CVD Management

George Grunberger, MD

2:45pm - 3:00pm

Panel Discussion & Live Q&A

Aug 24, 2020 (Eastern)
3:00pm - 3:39pm
Session 15: The Liver & The Heart

Session Chair: Derek LeRoith, MD

3:00pm - 3:20pm

NAFLD & the Heart as a Part of the Spectrum of Cardiometabolic Risk

Laurence Sperling, MD

3:20pm - 3:40pm

Emerging Management Options for NAFLD/NASH - Impact on Cardiometabolic Outcomes

Christos S. Mantzoros, MD

3:40pm - 3:55pm

Panel Discussion & Live Q&A

 

Aug 24, 2020 (Eastern)
3:39pm - 3:55pm
LIVE Q&A - Session 15: The Liver & The Heart

Session Chair: Derek LeRoith, MD

3:00pm - 3:20pm

NAFLD & the Heart as a Part of the Spectrum of Cardiometabolic Risk

Laurence Sperling, MD

3:20pm - 3:40pm

Emerging Management Options for NAFLD/NASH - Impact on Cardiometabolic Outcomes

Christos S. Mantzoros, MD

3:40pm - 3:55pm

Panel Discussion & Live Q&A

 

Aug 24, 2020 (Eastern)
3:55pm - 4:58pm
ABSTRACT ORAL PRESENTATION

3:55pm - 4:55pm

2020 ABSTRACT COMMITTEE: 

George Grunberger, MD *chair

Zachary T. Bloomgarden, MD

Matthew J. Budoff, MD

Vivian A. Fonseca, MD

Norman E. Lepor, MD

Derek LeRoith, MD, PhD

Laurence Sperling, MD

*Abstracts will be published in: American Heart Journal

Editor in Chief: Daniel Mark, MD, MPH

Aug 24, 2020 (Eastern)
4:58pm - 5:59pm
Day 4 Summary, Live Q&A

5:00pm - 6:00pm

Aug 24, 2020 (Eastern)
6:00pm - 7:03pm
REPLAY of SESSION 12 – GLP1-RA IN ASCVD & THE KIDNEY

Session Chairs: Richard E. Pratley, MD, Matthew R. Weir, MD

 

Mechanistic Insights into Cardiovascular Effects of GLP-1ra

Nikolaus Marx, MD

 

GLP1-ra Impact on the Kidney

Mark E. Cooper, AO, PhD

 

Role of GLP1-ra in Trials in HF Patients

Javed Butler, MD

 

Panel Discussion & Live Q&A